Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Marlo Blazer, PharmD, BCOP
Authored Items
Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia
David Campbell, PharmD, MS
,
James T. Kenney, RPh, MBA
,
Marlo Blazer, PharmD, BCOP
,
Lisa M. Bloudek, PharmD, MS
,
John Brokars, MS
,
Dinara Makenbaeva, MD, MBA
November 2019 Vol 12, No 7
in
Original Research
,
Practice Management
Last modified: December 3, 2019